Viral metagenomics and blood safety

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
Virginie Sauvage, Marc Eloit

Abstract

The characterization of the human blood-associated viral community (also called blood virome) is essential for epidemiological surveillance and to anticipate new potential threats for blood transfusion safety. Currently, the risk of blood-borne agent transmission of well-known viruses (HBV, HCV, HIV and HTLV) can be considered as under control in high-resource countries. However, other viruses unknown or unsuspected may be transmitted to recipients by blood-derived products. This is particularly relevant considering that a significant proportion of transfused patients are immunocompromised and more frequently subjected to fatal outcomes. Several measures to prevent transfusion transmission of unknown viruses have been implemented including the exclusion of at-risk donors, leukocyte reduction of donor blood, and physicochemical treatment of the different blood components. However, up to now there is no universal method for pathogen inactivation, which would be applicable for all types of blood components and, equally effective for all viral families. In addition, among available inactivation procedures of viral genomes, some of them are recognized to be less effective on non-enveloped viruses, and inadequate to inactivate higher...Continue Reading

References

Dec 1, 1991·Molecular and Cellular Probes·G R Reyes, J P Kim
Sep 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·T AllanderJ Bukh
Mar 23, 2004·Nature Medicine·Lia van der HoekBen Berkhout
Jan 19, 2008·Science·Huichen FengPatrick S Moore
Feb 8, 2008·The New England Journal of Medicine·Gustavo PalaciosW Ian Lipkin
Sep 6, 2008·BMC Molecular Biology·Nicolas BerthetJean-Claude Manuguerra
Nov 22, 2008·PLoS Pathogens·Jonathan S TownerStuart T Nichol
Feb 13, 2009·Journal of Virology·Joseph G VictoriaEric Delwart
Mar 21, 2009·Nature Protocols·Rebecca V ThurberForest Rohwer
Oct 10, 2009·Virology Journal·Stacy R FinkbeinerDavid Wang
Feb 11, 2010·Future Microbiology·Patrick Tang, Charles Chiu
May 29, 2010·Emerging Infectious Diseases·Phenix Lan QuanW Ian Lipkin
Feb 2, 2011·PloS One·Michel de VriesLia van der Hoek
Jul 1, 2011·Journal of Clinical Microbiology·Justine ChevalMarc Eloit
Aug 2, 2011·Emerging Infectious Diseases·Virginie SauvageMarc Eloit
Sep 2, 2011·Genome Research·Samuel MinotFrederic D Bushman
Sep 9, 2011·Journal of Virology·Tongling ShanEric Delwart
Sep 13, 2011·PLoS Pathogens·Tung G PhanEric L Delwart
Oct 4, 2011·Virology·Laura K McMullanStuart T Nichol
Nov 22, 2011·Emerging Infectious Diseases·Lori R HoltzDavid Wang
Jan 5, 2012·PloS One·Marta CanutiLia van der Hoek
Feb 2, 2012·PDA Journal of Pharmaceutical Science and Technology·David Onions
Jul 13, 2012·Journal of Virology·Virginie SauvageMarc Eloit
Aug 31, 2012·Journal of Virology·Terry Fei Fan NgEric Delwart
Sep 27, 2012·Viruses·Michel de VriesLia van der Hoek
Oct 3, 2012·PLoS Pathogens·Gilda GrardEric M Leroy
Oct 11, 2012·Revista brasileira de hematologia e hemoterapia·Patricia Marial SobralCristine Vieira do Bonfim
Dec 27, 2012·Nature Reviews. Microbiology·W Ian Lipkin
Mar 26, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Luisa BarzonGiorgio Palù
May 15, 2013·BMC Genomics·Sergei A SolonenkoMatthew B Sullivan
May 30, 2013·Proceedings of the National Academy of Sciences of the United States of America·Baoyan XuNeal S Young
Jul 4, 2013·The Journal of Infectious Diseases·Nikolay PopgeorgievChristelle Desnues
Jul 12, 2013·The ISME Journal·Jessica M Labonté, Curtis A Suttle
Sep 5, 2013·MBio·Simon J AnthonyW Ian Lipkin
Sep 17, 2013·Journal of Virological Methods·Richard J HallMatthew Peacey
Nov 5, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Nikolay PopgeorgievChristelle Desnues

❮ Previous
Next ❯

Citations

Jan 17, 2017·Nature Reviews. Microbiology·Charlotte J HouldcroftJudith Breuer
Mar 23, 2017·PLoS Pathogens·Ahmed MoustafaAmalio Telenti
May 13, 2017·Transfusion·Pierre LauOlivier Preynat-Seauve
Jan 2, 2018·Virusdisease·Mageshbabu RamamurthyGopalan Sridharan
Jul 21, 2017·Journal of Clinical Microbiology·Susanna K TanBenjamin A Pinsky
Oct 14, 2017·Mobile DNA·Varun AggarwalaFrederic D Bushman
Aug 31, 2017·Scientific Reports·Andrei A DeviatkinGerman A Shipulin
Mar 27, 2021·Scientific Reports·María Cebriá-MendozaJosé M Cuevas
Aug 21, 2021·Transfusion clinique et biologique : journal de la Société française de transfusion sanguine·Tomislav VukConstantina Politis
Dec 7, 2021·Frontiers in Medicine·Kotakonda ArunasriSisinthy Shivaji

❮ Previous
Next ❯

Methods Mentioned

BETA
membrane filtration
MDA
PCR
enzymatic shearing
chips
chip
nucleic

Software Mentioned

SURPI
PromethION
MinION
VIDISCA
VirCapSeq
PacBioRS
PathoQuest
Ion
Blast

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Transfusion clinique et biologique : journal de la Société française de transfusion sanguine
Virginie SauvageSyria Laperche
Current Opinion in Virology
Karyna Rosario, Mya Breitbart
Indian Journal of Virology : an Official Organ of Indian Virological Society
S V Alavandi, M Poornima
© 2022 Meta ULC. All rights reserved